<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font16 { font-size : 16; } .font21 { font-size : 21; } .font22 { font-size : 22; } .font24 { font-size : 24; } .font10 { font-size : 10; } .font11 { font-size : 11; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font30 { font-size : 30; } .font14 { font-size : 14; } .font15 { font-size : 15; }</style>
 <body>
  <p>
   <span class="font30">patients </span>
   <span class="font24">(%) </span>
   <span class="font24">influenza </span>
   <span class="font22">severe </span>
   <span class="font21">respiratory </span>
   <span class="font16">acute </span>
   <span class="font15">ill </span>
   <span class="font15">treatment </span>
   <span class="font14">oseltamivir </span>
   <span class="font14">Influenza </span>
   <span class="font14">trial </span>
   <span class="font14">critically </span>
   <span class="font14">clinical </span>
   <span class="font14">Care </span>
   <span class="font14">mortality </span>
   <span class="font14">viral </span>
   <span class="font14">associated </span>
   <span class="font13">hospitalized </span>
   <span class="font13">Med </span>
   <span class="font13">infection </span>
   <span class="font13">ventilation </span>
   <span class="font13">therapy </span>
   <span class="font13">ARDS </span>
   <span class="font13">virus </span>
   <span class="font13">{border-style </span>
   <span class="font12">study </span>
   <span class="font12">pneumonia </span>
   <span class="font12">px;} </span>
   <span class="font12">syndrome </span>
   <span class="font12">#ffffff;} </span>
   <span class="font12">NIV </span>
   <span class="font12">RVIs </span>
   <span class="font12">collab: </span>
   <span class="font12">Infect </span>
   <span class="font12">care </span>
   <span class="font12">distress </span>
   <span class="font12">Chan </span>
   <span class="font12">Dis </span>
   <span class="font12">RVI </span>
   <span class="font12">use </span>
   <span class="font12">ICU </span>
   <span class="font12">compared </span>
   <span class="font12">failure </span>
   <span class="font12">adults </span>
   <span class="font12">studies </span>
   <span class="font11">(.%) </span>
   <span class="font11">NAAT </span>
   <span class="font11">RCT </span>
   <span class="font11">Respir </span>
   <span class="font11">data </span>
   <span class="font11">infections </span>
   <span class="font11">management </span>
   <span class="font11">A(HN)pdm </span>
   <span class="font11">Hayden </span>
   <span class="font11">Respiratory </span>
   <span class="font11">agents </span>
   <span class="font11">community-acquired </span>
   <span class="font11">risk </span>
   <span class="font11">viruses </span>
   <span class="font11">A(HN) </span>
   <span class="font11">Clin </span>
   <span class="font11">Critical </span>
   <span class="font11">Engl </span>
   <span class="font11">Lee </span>
   <span class="font11">Wong </span>
   <span class="font11">admitted </span>
   <span class="font11">antiviral </span>
   <span class="font11">benefit </span>
   <span class="font11">invasive </span>
   <span class="font11">pathogens </span>
   <span class="font11">recent </span>
   <span class="font11">./NEJMoa </span>
   <span class="font11">Acute </span>
   <span class="font11">East </span>
   <span class="font11">However, </span>
   <span class="font11">Intensive </span>
   <span class="font11">JAMA </span>
   <span class="font11">dose </span>
   <span class="font11">duration </span>
   <span class="font11">early </span>
   <span class="font11">healthcare </span>
   <span class="font11">higher </span>
   <span class="font11">illness </span>
   <span class="font11">including </span>
   <span class="font11">influenza, </span>
   <span class="font11">inhibitor </span>
   <span class="font11">novel </span>
   <span class="font11">recommended </span>
   <span class="font11">reported </span>
   <span class="font11">standard </span>
   <span class="font11">strains </span>
   <span class="font11">trials </span>
   <span class="font11">used </span>
   <span class="font11">./jama.. </span>
   <span class="font11">Antiviral </span>
   <span class="font11">Arabi </span>
   <span class="font11">BAL </span>
   <span class="font11">Crit </span>
   <span class="font11">Fowler </span>
   <span class="font11">Group </span>
   <span class="font11">Intravenous </span>
   <span class="font11">Liu </span>
   <span class="font11">Rhinovirus </span>
   <span class="font11">Severe </span>
   <span class="font11">Trials </span>
   <span class="font11">combination </span>
   <span class="font11">demonstrated </span>
   <span class="font11">improved </span>
   <span class="font11">inhibitors </span>
   <span class="font11">intravenous </span>
   <span class="font11">lung </span>
   <span class="font11">nasal </span>
   <span class="font11">oxygenation </span>
   <span class="font11">patients. </span>
   <span class="font11">px; </span>
   <span class="font11">randomized </span>
   <span class="font11">reduced </span>
   <span class="font11">{font-family </span>
   <span class="font11">-day </span>
   <span class="font11">ECMO </span>
   <span class="font11">Lin </span>
   <span class="font11">MERS </span>
   <span class="font11">Middle </span>
   <span class="font11">Syndrome </span>
   <span class="font11">Table </span>
   <span class="font11">[], </span>
   <span class="font11">addition </span>
   <span class="font11">analysis </span>
   <span class="font11">approved </span>
   <span class="font11">font-size </span>
   <span class="font11">high </span>
   <span class="font11">human </span>
   <span class="font11">hypoxemic </span>
   <span class="font11">intubation </span>
   <span class="font11">lower </span>
   <span class="font11">masks </span>
   <span class="font11">mechanical </span>
   <span class="font11">membrane </span>
   <span class="font11">multicenter </span>
   <span class="font11">neuraminidase </span>
   <span class="font11">patients, </span>
   <span class="font11">supportive </span>
   <span class="font11">syncytial </span>
   <span class="font11">transmission </span>
   <span class="font11">zanamivir </span>
   <span class="font10">Beigel </span>
   <span class="font10">CAP </span>
   <span class="font10">Investigators </span>
   <span class="font10">Lancet </span>
   <span class="font10">NAI </span>
   <span class="font10">Oral </span>
   <span class="font10">PS, </span>
   <span class="font10">RSV </span>
   <span class="font10">adjunctive </span>
   <span class="font10">adult </span>
   <span class="font10">coronavirus </span>
   <span class="font10">coronaviruses </span>
   <span class="font10">corticosteroid </span>
   <span class="font10">double; </span>
   <span class="font10">formulation </span>
   <span class="font10">grid.. </span>
   <span class="font10">hand </span>
   <span class="font10">increased </span>
   <span class="font10">need </span>
   <span class="font10">n = ), </span>
   <span class="font10">n = , </span>
   <span class="font10">observational </span>
   <span class="font10">phase </span>
   <span class="font10">pneumonia) </span>
   <span class="font10">positive </span>
   <span class="font10">precautions </span>
   <span class="font10">resistance </span>
   <span class="font10">secondary </span>
   <span class="font10">significant </span>
   <span class="font10">survival </span>
   <span class="font10">tract </span>
   <span class="font10">virus, </span>
   <span class="font10">Clark </span>
   <span class="font10">Clinical </span>
   <span class="font10">Cook </span>
   <span class="font10">Data </span>
   <span class="font10">Enterovirus </span>
   <span class="font10">Ferguson </span>
   <span class="font10">France </span>
   <span class="font10">HFOV </span>
   <span class="font10">Health </span>
   <span class="font10">Huang </span>
   <span class="font10">Hui </span>
   <span class="font10">Medicine, </span>
   <span class="font10">RVI. </span>
   <span class="font10">Slutsky </span>
   <span class="font10">available </span>
   <span class="font10">bacterial </span>
   <span class="font10">baloxavir </span>
   <span class="font10">border-color </span>
   <span class="font10">border-width </span>
   <span class="font10">cannula </span>
   <span class="font10">cause </span>
   <span class="font10">days </span>
   <span class="font10">did </span>
   <span class="font10">effect </span>
   <span class="font10">effective </span>
   <span class="font10">immunocompromised </span>
   <span class="font10">injury </span>
   <span class="font10">levels </span>
   <span class="font10">like </span>
   <span class="font10">meta-analysis </span>
   <span class="font10">n = ) </span>
   <span class="font10">oral </span>
   <span class="font10">outcomes </span>
   <span class="font10">patient </span>
   <span class="font10">pharmacologic </span>
   <span class="font10">placebo </span>
   <span class="font10">plasma </span>
   <span class="font10">randomized-controlled </span>
   <span class="font10">reduction </span>
   <span class="font10">refer </span>
   <span class="font10">resistant </span>
   <span class="font10">review </span>
   <span class="font10">seasonal </span>
   <span class="font10">showed </span>
   <span class="font10">sirolimus </span>
   <span class="font10">solid; </span>
   <span class="font10">travel </span>
   <span class="font10">versus </span>
   <span class="font10">vitamin </span>
   <span class="font10">workers </span>
   <span class="font10">{font-style </span>
   <span class="font10">{font-weight </span>
   <span class="font10">(E, </span>
   <span class="font10">(RVIs) </span>
   <span class="font10">(Table </span>
   <span class="font10">(rhinovirus, </span>
   <span class="font10">./S-()- </span>
   <span class="font10">./s--- </span>
   <span class="font10">Airborne  contact </span>
   <span class="font10">Al-Hameed </span>
   <span class="font10">Al-Omari </span>
   <span class="font10">Alraddadi </span>
   <span class="font10">Brochard </span>
   <span class="font10">Chen </span>
   <span class="font10">Chest </span>
   <span class="font10">Contact </span>
   <span class="font10">Davey </span>
   <span class="font10">Diseases </span>
   <span class="font10">Drug </span>
   <span class="font10">Early </span>
   <span class="font10">Effect </span>
   <span class="font10">Extracorporeal </span>
   <span class="font10">High-flow </span>
   <span class="font10">Human </span>
   <span class="font10">Hung </span>
   <span class="font10">IFA, </span>
   <span class="font10">IMV </span>
   <span class="font10">Infectious </span>
   <span class="font10">Lamontagne </span>
   <span class="font10">Lane </span>
   <span class="font10">Lau </span>
   <span class="font10">MERS-CoV </span>
   <span class="font10">Meade </span>
   <span class="font10">Mercat </span>
   <span class="font10">NL, </span>
   <span class="font10">OC, </span>
   <span class="font10">Patients </span>
   <span class="font10">RNA </span>
   <span class="font10">RVIs. </span>
   <span class="font10">Research </span>
   <span class="font10">Richard </span>
   <span class="font10">SARS </span>
   <span class="font10">Saudi </span>
   <span class="font10">Thompson </span>
   <span class="font10">Trial </span>
   <span class="font10">Uncommon </span>
   <span class="font10">University </span>
   <span class="font10">Uyeki </span>
   <span class="font10">Wang </span>
   <span class="font10">Zhang </span>
   <span class="font10">Zhou </span>
   <span class="font10">adenovirus </span>
   <span class="font10">anti-influenza </span>
   <span class="font10">antibody </span>
   <span class="font10">avian </span>
   <span class="font10">blockers </span>
   <span class="font10">bold </span>
   <span class="font10">causing </span>
   <span class="font10">clearance </span>
   <span class="font10">cohort </span>
   <span class="font10">commercial </span>
   <span class="font10">control </span>
   <span class="font10">corticosteroids </span>
   <span class="font10">courier; </span>
   <span class="font10">current </span>
   <span class="font10">detected </span>
   <span class="font10">different </span>
   <span class="font10">double-blind, </span>
   <span class="font10">effects, </span>
   <span class="font10">efficient </span>
   <span class="font10">em; </span>
   <span class="font10">extracorporeal </span>
   <span class="font10">failure, </span>
   <span class="font10">failure. </span>
   <span class="font10">findings </span>
   <span class="font10">fluid </span>
   <span class="font10">health </span>
   <span class="font10">high-flow </span>
   <span class="font10">hospital </span>
   <span class="font10">include </span>
   <span class="font10">individual </span>
   <span class="font10">leading </span>
   <span class="font10">mechanically </span>
   <span class="font10">medical </span>
   <span class="font10">noninvasive </span>
   <span class="font10">online </span>
   <span class="font10">organ </span>
   <span class="font10">outcome </span>
   <span class="font10">pandemic </span>
   <span class="font10">pneumonia), </span>
   <span class="font10">positioning </span>
   <span class="font10">possible </span>
   <span class="font10">practice </span>
   <span class="font10">pressure </span>
   <span class="font10">prevalence </span>
   <span class="font10">primary </span>
   <span class="font10">procedures </span>
   <span class="font10">pt;} </span>
   <span class="font10">pulmonary </span>
   <span class="font10">requiring </span>
   <span class="font10">research </span>
   <span class="font10">responses </span>
   <span class="font10">results </span>
   <span class="font10">severely </span>
   <span class="font10">small </span>
   <span class="font10">specific </span>
   <span class="font10">strategies </span>
   <span class="font10">strategy </span>
   <span class="font10">studied </span>
   <span class="font10">studies, </span>
   <span class="font10">supplementary </span>
   <span class="font10">syndrome: </span>
   <span class="font10">systemic </span>
   <span class="font10">test </span>
   <span class="font10">uncertain </span>
   <span class="font10">ventilated </span>
  </p>
 </body>
</html>
